DJ US Healthcare Ishares (IYH) 159.39 $IYH Relative Risk

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
DJ US Healthcare Ishares (IYH) 159.39 $IYH

Relative Risk Adjusted Return For Retirees And Those Who Prefer A Smoother Ride
Richard Shaw - at Seeking Alpha - Sat Mar 21, 12:17AM CDT

SPYG: 101.17 (+0.50), IYH: 159.39 (+0.86), VDC: 126.95 (+1.49), XLY: 76.77 (+0.59), IYC: 147.34 (+1.37), IBB: 366.52 (+1.27), XLV: 74.90 (+0.33), IVW: 117.19 (+0.95), VUG: 110.43 (+0.93), FVD: 24.42 (+0.25), XLP: 48.94 (+0.31), VCR: 124.36 (+1.22), JKE: 121.98 (+1.00), JKG: 155.25 (+1.49), IWF: 101.20 (+0.78), IXJ: 110.64 (+1.24), VHT: 139.38 (+0.70)

What To Expect When The Fed Actually Does Raise Rates
Dirk Leach - at Seeking Alpha - Thu Mar 19, 4:28PM CDT

RYH: 159.00 (+0.69), KXI: 92.72 (+1.23), IYH: 159.39 (+0.86), VDC: 126.95 (+1.49), IPS: 41.06 (+0.45), RXL: 149.91 (+1.63), XLV: 74.90 (+0.33), XLP: 48.94 (+0.31), SPY: 210.41 (+0.91), FSTA: 29.55 (+0.05), QQQ: 108.53 (+0.45), DIA: 180.96 (+1.30), FHLC: 36.29 (-0.04), RXD: 12.24 (-0.14), RHS: 107.06 (+0.54), IWM: 125.99 (+1.10), FXG: 45.17 (+0.30), CURE: 161.18 (+3.49), VHT: 139.38 (+0.70), FXH: 68.50 (+0.07)

Developing An Eye For R&D
The Financialist - Seeking Alpha - Tue Mar 17, 5:24AM CDT
Despite the strong economic recovery in the U.S., nominal global GDP growth over the next few years is unlikely to reach the levels reached just prior to the global financial crisis. Developed economies grew an average of 5 percent between 1997 and...
IYJ: 109.99 (+0.71), IYH: 159.39 (+0.86), IXJ: 110.64 (+1.24), IYW: 107.91 (+0.62)

12 Best Biotech and Health Care ETFs to Add to Your Portfolio
at The Street - Thu Mar 12, 9:49AM CDT
Biotech and health care are two of the hottest sectors in which to invest. TheStreet compiled a list of the best-rated ETFs tracking the two sectors.
IHE: 178.85 (-0.32), IHF: 134.41 (+0.34), XHE: 95.03 (-0.32), IYH: 159.39 (+0.86), XHS: 125.51 (+0.62), GRX: 11.23 (+0.07), FHLC: 36.29 (-0.04), IHI: 120.98 (+0.18), IXJ: 110.64 (+1.24), VHT: 139.38 (+0.70), FXH: 68.50 (+0.07), XLV: 74.90 (+0.33)

Healthcare Funds: Hale And Hearty
Morningstar - Seeking Alpha - Wed Mar 11, 11:39AM CDT
By Robert Goldsborough The healthcare sector's returns have continued to be very potent. More than almost any other corner of the U.S. equity market, healthcare stocks have dazzled in recent years, including the nearly five years since President...
IYH: 159.39 (+0.86), FHLC: 36.29 (-0.04), VHT: 139.38 (+0.70), XLV: 74.90 (+0.33)

Investors Find A Reason To Sell, Teeing Up A New Buying Opportunity
Scott Martindale - at Seeking Alpha - Mon Mar 09, 2:16PM CDT
When I'm in my sales role, I view every prospective client as falling into one of two broad baskets: those looking for a reason to say yes, and those looking for a reason to say no. I always try to focus on the former and spend little time on the...
IYK: 105.91 (+1.16), IYJ: 109.99 (+0.71), XTN: 111.14 (+0.79), IYH: 159.39 (+0.86), SWKS: 102.05 (+2.48), LSTR: 68.91 (+0.90), BBT: 39.81 (+0.25), IYM: 82.53 (+0.67), IYC: 147.34 (+1.37), XOM: 84.54 (+0.13), IYF: 91.39 (+1.22), IYE: 43.63 (+0.61), FMER: 19.42 (+0.31), IYZ: 31.26 (+0.37), SPY: 210.41 (+0.91), PSI: 28.21 (+0.45), IDU: 113.91 (+1.13), CAR: 58.88 (-0.05), CRUS: 33.72 (+0.34), IAT: 35.65 (+0.44), AAPL: 125.90 (-1.60), IYW: 107.91 (+0.62)

ETF flows: Out of financials, industrials, tech; into energy, healthcare
Seeking Alpha - at Seeking Alpha - Thu Mar 05, 1:08PM CST

UYG: 152.26 (+3.86), ROM: 161.96 (+2.30), QTEC: 44.99 (+0.46), FXL: 36.80 (+0.33), ERY: 20.70 (-0.95), RGI: 91.32 (+0.42), TECL: 150.33 (+2.54), ERX: 54.14 (+2.35), FXN: 20.99 (+0.27), FXO: 23.99 (+0.28), FNCL: 29.40 (+0.25), FAS: 130.56 (+4.47), FAZ: 11.64 (-0.46), FXH: 68.50 (+0.07), SEF: 17.19 (-0.22), VFH: 50.46 (+0.70), DDG: 26.19 (-0.47), REW: 50.64 (-0.80), UXI: 122.90 (+0.65), SIJ: 39.35 (unch), TECS: 9.91 (-0.16), FIDU: 29.35 (+0.13), FTEC: 32.82 (+0.06), FENY: 22.06 (+0.16), RWW: 49.89 (+0.52), RXD: 12.24 (-0.14), OIH: 33.30 (+0.74), RXL: 149.91 (+1.63), AIRR: 18.60 (+0.25), DUG: 54.08 (-1.44), PXJ: 15.98 (+0.23), VIS: 109.27 (+0.65), XLK: 42.54 (+0.10), FHLC: 36.29 (-0.04), XLI: 57.12 (+0.06), XLF: 24.71 (+0.24), RYE: 65.15 (+0.69), RYF: 45.57 (+0.43), CURE: 161.18 (+3.49), VHT: 139.38 (+0.70), XLE: 76.91 (+0.60), IYW: 107.91 (+0.62), FINZ: 20.88 (-1.18), RYH: 159.00 (+0.69), VDE: 108.48 (+1.29), IYJ: 109.99 (+0.71), IYH: 159.39 (+0.86), IGM: 106.03 (+0.92), DIG: 50.34 (+1.28), FINU: 89.26 (+3.59), IYG: 91.93 (+1.01), RYT: 94.16 (+0.66), IYF: 91.39 (+1.22), IYE: 43.63 (+0.61), XLV: 74.90 (+0.33), FXR: 31.61 (+0.24), MTK: 103.47 (+0.66), VGT: 108.77 (+0.62)

Stocks Break Out Again But May Be Running On Fumes
Scott Martindale - at Seeking Alpha - Tue Mar 03, 12:42AM CST
Despite low trading volume, a strong dollar, mixed economic and earnings reports, paralyzing weather conditions throughout much of the U.S., and ominous global news events, stocks continue to march ever higher. The world remains on edge about...
IYK: 105.91 (+1.16), IYJ: 109.99 (+0.71), VRX: 204.26 (+2.17), IYH: 159.39 (+0.86), IYM: 82.53 (+0.67), SLXP: 172.80 (+0.26), IYC: 147.34 (+1.37), ICE: 236.70 (-0.01), JBLU: 19.48 (+0.11), NXPI: 108.03 (+2.71), IYG: 91.93 (+1.01), BRCD: 12.37 (+0.16), IYF: 91.39 (+1.22), IYE: 43.63 (+0.61), IYZ: 31.26 (+0.37), SPY: 210.41 (+0.91), COMM: 30.86 (+0.25), AMG: 219.29 (+5.85), IDU: 113.91 (+1.13), IGN: 38.56 (+0.23), IYT: 164.35 (+0.32), FSL: 43.39 (+0.82), UNP: 117.45 (-0.10), IYW: 107.91 (+0.62)

Sector Rankings Stay Neutral With Few Bullish Catalysts On Horizon
Scott Martindale - at Seeking Alpha - Wed Feb 18, 12:49AM CST
Stocks are hitting new highs across the board, even though earnings reports have been somewhat disappointing. Actually, to be more precise, Q4 results have been pretty good, but it is forward guidance that has been cautious and/or cloudy as sales...
IYK: 105.91 (+1.16), ACHC: 72.77 (+1.17), IYJ: 109.99 (+0.71), BX: 38.69 (unch), IYH: 159.39 (+0.86), IYM: 82.53 (+0.67), IYC: 147.34 (+1.37), AMP: 136.17 (+2.83), IYF: 91.39 (+1.22), IYE: 43.63 (+0.61), KBWI: 69.39 (-0.26), IHF: 134.41 (+0.34), IYZ: 31.26 (+0.37), SPY: 210.41 (+0.91), MRVL: 15.72 (-0.08), IDU: 113.91 (+1.13), FONE: 40.83 (+0.46), MD: 72.46 (+0.32), AVGO: 133.29 (+1.25), IYW: 107.91 (+0.62)

Profiling Health Care ETFs - Why Medicine Is The Best Medicine
Aaron Barton - at Seeking Alpha - Thu Feb 12, 10:39AM CST

IYH: 159.39 (+0.86), PSCH: 68.93 (+0.03), FHLC: 36.29 (-0.04), IXJ: 110.64 (+1.24), VHT: 139.38 (+0.70), FXH: 68.50 (+0.07), XLV: 74.90 (+0.33)

Neutral Indicators And Mixed Reports, But Sector Rotation Model Is Bullish
Scott Martindale - at Seeking Alpha - Tue Feb 10, 12:20AM CST
Volatility continues as the parade of mixed earnings and economic reports marches along amidst a backdrop of global unrest and economic uncertainties. This has led to a neutral near-term outlook for both the technical picture and fundamentals-based...
IYK: 105.91 (+1.16), IYJ: 109.99 (+0.71), IYH: 159.39 (+0.86), IYM: 82.53 (+0.67), MCHP: 50.87 (+0.57), IYC: 147.34 (+1.37), AMP: 136.17 (+2.83), TDW: 20.59 (-0.68), TAN: 45.34 (+0.88), ALL: 71.46 (+0.86), IYF: 91.39 (+1.22), IYE: 43.63 (+0.61), KBWI: 69.39 (-0.26), IYZ: 31.26 (+0.37), FSLR: 60.26 (-0.04), SPY: 210.41 (+0.91), IDU: 113.91 (+1.13), XSD: 91.12 (+1.02), IYW: 107.91 (+0.62), CODE: 38.59 (+0.47)

Pfizer Set to Acquire Hospira: Healthcare ETFs in Focus - ETF News And Commentary
Sweta Killa - Zacks Investment Research - Fri Feb 06, 9:00AM CST
Healthcare ETFs are worth a look given that Pfizer will buy Hospira.
IHE: 178.85 (-0.32), PPH: 71.99 (+0.73), IYH: 159.39 (+0.86), PFE: 34.25 (+0.10), HSP: 87.64 (-0.06), XLV: 74.90 (+0.33)

Volatility Continues As Earnings Reports Create Excitement And Despair
Scott Martindale - at Seeking Alpha - Mon Feb 02, 9:02PM CST
Volatility reigned in January on elevated volume as stock investors shifted their focus from global events to U.S. earnings reports, which have ranged from amazing (e.g., Apple) to crushing (e.g., Microsoft). Although the earnings reports have...
IYK: 105.91 (+1.16), BIIB: 475.98 (+42.33), CAVM: 73.81 (+1.33), IYJ: 109.99 (+0.71), KBWD: 25.67 (+0.28), IYH: 159.39 (+0.86), IYM: 82.53 (+0.67), IYC: 147.34 (+1.37), IBB: 366.52 (+1.27), SMH: 57.74 (+0.90), IT: 83.03 (+1.30), IYF: 91.39 (+1.22), IYE: 43.63 (+0.61), STWD: 24.51 (+0.35), IYZ: 31.26 (+0.37), SPY: 210.41 (+0.91), SUI: 71.27 (+2.30), IDU: 113.91 (+1.13), SHPG: 253.64 (+3.07), IYW: 107.91 (+0.62)

With The Fed Fading Into The Shadows, Investors Look Overseas For New Catalysts
Scott Martindale - at Seeking Alpha - Mon Jan 26, 1:50AM CST
Last week, the S&P 500 put an end to its streak of weekly losses, despite giving back some gains on Friday. Thursday provided the big catalyst, with the ECB's announcement of its bold new monetary stimulus plan. Investors were cheered and soothed...
AMBA: 72.39 (+3.14), IYK: 105.91 (+1.16), IYJ: 109.99 (+0.71), PCYC: 257.85 (-0.21), IYH: 159.39 (+0.86), SPG: 197.34 (+5.24), IYM: 82.53 (+0.67), INCY: 95.55 (-1.53), IYC: 147.34 (+1.37), IBB: 366.52 (+1.27), IYF: 91.39 (+1.22), IYE: 43.63 (+0.61), KBWI: 69.39 (-0.26), IYZ: 31.26 (+0.37), SPY: 210.41 (+0.91), PSI: 28.21 (+0.45), IDU: 113.91 (+1.13), PVTB: 35.86 (-0.09), IYW: 107.91 (+0.62), CODE: 38.59 (+0.47)

Healthcare ETFs in Focus on Mixed JNJ Results - ETF News And Commentary
Sweta Killa - Zacks Investment Research - Wed Jan 21, 12:00PM CST
Healthcare ETFs are worth look following Johnson & Johnson mixed fourth quarter results.
JNJ: 102.40 (+0.71), IYH: 159.39 (+0.86), GILD: 102.29 (+0.85), VHT: 139.38 (+0.70), XLV: 74.90 (+0.33)

New Year Kicks Off With New Fears To Keep Investors On Edge
Scott Martindale - Seeking Alpha - Tue Jan 20, 4:47AM CST
As widely expected, the new year has begun with a lot of volatility on high trading volume, as investors fear more than just a mild correction to start out the year. Despite the strong fundamentals here in the U.S., there are plenty of dangers around...
IYK: 105.91 (+1.16), IYJ: 109.99 (+0.71), ACT: 317.06 (+2.65), IYH: 159.39 (+0.86), IYM: 82.53 (+0.67), UNH: 119.14 (-1.62), PSA: 199.12 (+4.88), IYC: 147.34 (+1.37), SMH: 57.74 (+0.90), NXPI: 108.03 (+2.71), IT: 83.03 (+1.30), IYF: 91.39 (+1.22), IYE: 43.63 (+0.61), LUV: 46.36 (+0.01), JLL: 169.56 (+5.10), PPH: 71.99 (+0.73), IYZ: 31.26 (+0.37), SPY: 210.41 (+0.91), IDU: 113.91 (+1.13), REM: 12.05 (+0.10), TYL: 125.29 (+1.82), IDXX: 152.80 (-1.65), IYW: 107.91 (+0.62)

Where Do Cures Reside? The Answer Is In Regenerative Medicine
Life Sciences Report - Seeking Alpha - Fri Jan 09, 7:37AM CST
The practice of medicine is being transformed. The journey has been arduous, but revolutionary stem cell, gene and immunocellular therapies are rapidly moving toward pivotal milestones-and investors in the space should strap in for a rewarding joy...
BBP: 32.37 (-0.23), RXL: 149.91 (+1.63), XBI: 233.86 (-4.12), IHE: 178.85 (-0.32), IHF: 134.41 (+0.34), PPH: 71.99 (+0.73), XHE: 95.03 (-0.32), BBC: 35.07 (-0.58), PTH: 63.31 (-0.61), BBH: 138.45 (+0.69), FHLC: 36.29 (-0.04), IHI: 120.98 (+0.18), CURE: 161.18 (+3.49), FXH: 68.50 (+0.07), VHT: 139.38 (+0.70), RYH: 159.00 (+0.69), PBE: 58.47 (-0.79), IYH: 159.39 (+0.86), FBT: 125.71 (-0.27), XHS: 125.51 (+0.62), XPH: 130.00 (-1.39), XLV: 74.90 (+0.33), SBIO: 31.04 (-0.89), PSCH: 68.93 (+0.03), PJP: 80.41 (+0.33), RXD: 12.24 (-0.14)

Kyle Bass's Assault On Pharma Patents
IP Hawk - at Seeking Alpha - Thu Jan 08, 12:25PM CST

BBP: 32.37 (-0.23), RXL: 149.91 (+1.63), XBI: 233.86 (-4.12), IBB: 366.52 (+1.27), IHE: 178.85 (-0.32), IHF: 134.41 (+0.34), BBC: 35.07 (-0.58), PPH: 71.99 (+0.73), XHE: 95.03 (-0.32), PTH: 63.31 (-0.61), BBH: 138.45 (+0.69), FHLC: 36.29 (-0.04), IHI: 120.98 (+0.18), CURE: 161.18 (+3.49), FXH: 68.50 (+0.07), VHT: 139.38 (+0.70), RYH: 159.00 (+0.69), PBE: 58.47 (-0.79), IYH: 159.39 (+0.86), FBT: 125.71 (-0.27), XHS: 125.51 (+0.62), XPH: 130.00 (-1.39), XLV: 74.90 (+0.33), SBIO: 31.04 (-0.89), PSCH: 68.93 (+0.03), PJP: 80.41 (+0.33), RXD: 12.24 (-0.14)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Copper Peptides Shine in New Renue Blue Cream

Updated Category News Views 171

Renue By Science's Ambitious Skincare Launch Alright, we've got a big player stepping up in the realm of skincare with a new face cream packed tightly with science-backed goodies. Renue By Science is revamping their game by anchoring their new Renue Blue Face Cream around the star of the moment: copper tripeptide-1, also known as GHK-Cu. This is more than a beauty gloss...

Continue Reading
Elah Holdings' Q3 2026 Report Sparks Investor Interest

Updated Category News Views 79

Elah Holdings Drops Their Q3 2026 Numbers Eat your heart out, folks—Elah Holdings has just dropped their third quarter report for 2026, and it caught some eyes. This ain't your run-of-the-mill, brush-right-past-it release. They're out there, waving their flag high in the competitive marketplace, trying to tell us they mean business. If you missed the announcement, they...

Continue Reading
Cracking Life Insurance Needs: John Dorsa's Insights

Updated Category News Views 137

Life Insurance: A Necessary Puzzle Life’s uncertainties have a way of putting a wrench in our plans, and nothing screams uncertainty like figuring out life insurance. But fret not! HelloNation’s got insights on this financial maze, and they’ve roped in insurance pro John Dorsa from Ridgeland to help out. Calculating Coverage Needs Forget the one-size-fits-all...

Continue Reading
Choate's Expands to New Mid-South Markets

Updated Category News Views 171

Family Traditions Drive Choate's Growth Back in the day, you might've thought the family-run businesses were a dying breed, right? Not in the case of Choate's Air Conditioning, Heating, Plumbing & Electrical. These folks aren't just holding the fort; they're storming new territories across the Mid-South like they've got something to prove—or maybe just something to...

Continue Reading
Texxon Faces Revenue Slide Amid Strategic Shifts

Updated Category News Views 155

Texxon's Strategic Transitions and Financial Headaches Texxon Holding Limited (NASDAQ:NPT) just laid their cards on the table, unveiling a mixed bag in their fiscal year 2026 results. As the world's chemical and plastics scene faces winds of change, Texxon buckled down and tried to steer the ship clear from the rocks. It's a balancing act juggling market headwinds, a new...

Continue Reading
Epic Legal Battle Yields $63M Verdict Against Chevron

Updated Category News Views 359

A David vs. Goliath Showdown in Court How's this for a courtroom drama? Picture eight lawyers taking on Chevron over a toxic pit buried beneath an unsuspecting family's home. These folks at Ernst Law Group and Trial Lawyers for Justice tackled Union Oil (now Chevron) and bagged a staggering $63 million for their client. This ain't your run-of-the-mill legal squabble; it's...

Continue Reading
AI Alliance Rethinks Health Plan Engagement

Updated Category News Views 139

Building Bridges in Healthcare Ever seen healthcare stuck in its own muck with disconnected gears attempting to move the same machine? Well, that's precisely the mountain healthplans.ai and URAWARRIOR aim to climb down from. Founders Rachel Spilo and Dr. Bershan Shaw are gearing up to shake hands in their no-nonsense, real-world vow to sync member engagement with the...

Continue Reading
The Melt Grabs Top Spot in Burger Ratings War

Updated Category News Views 122

Burger Battle: The Melt Claims Victory When you're in the cutthroat world of fast-casual dining, grabbing the top spot on any list is no small potatoes. The Melt did just that, snatching the title of America’s Highest-Rated Burger Spot. Based on an in-depth analysis of Google and Yelp reviews, folks have spoken, loud and clear, over the past two years. It's a world...

Continue Reading
Philadelphia Firm Targets 100 Toys for Children This Holiday

Updated Category News Views 0

A hundred unopened toys can look modest on paper, yet that is exactly why this Philadelphia effort lands differently than the usual chest-thumping corporate charity chatter. van der Veen, Hartshorn & Levin has set a clear holiday target: collect 100 new, unwrapped toys for children in the Philadelphia area through the U.S. Marine Corps Reserve Toys for Tots program. No...

Continue Reading
LifeVac's 7,000 Reported Saves Deserve Careful Context

Updated Category News Views 0

Veggie straws are supposed to be harmless until they are not. LifeVac says a 19-month-old girl in South Dakota became unable to breathe on November 14 after eating the snack, with a sticky piece creating a complete airway obstruction. Her father retrieved the family's LifeVac, used the pediatric mask while she was on her back, and the company says one application...

Continue Reading

Top 5 Most Recently Viewed Articles

Síminn hf. Achieves Strong Growth in Q2 2025 Results

Updated Category News Views 303

Exciting Financial Highlights from Síminn hf. for Q2 2025 In the second quarter of 2025, Síminn hf. reported remarkable financial growth, demonstrating their resilient operations and commitment to enhancing customer value. The total revenue surged to ISK 7,196 million, marking a 4.7% increase compared to Q2 2024, where revenues stood at ISK 6,871 million. This positive...

Continue Reading
Pacesetter Joins Inc.'s 2026 Best Workplaces List

Updated Category News Views 33

Pacesetter Technology Earns a Spot on Inc.'s Renowned List How many times have we heard companies rattle on about employee satisfaction and culture? But this time, we're talking about a company, Pacesetter Technology, that didn't just talk the talk—they walked right into Inc.'s 2026 Best Workplaces spotlight. And in an era where employers hold all the cards, that's no...

Continue Reading
Discover Meiyume's Innovative Beauty Solutions at Cosmopack

Updated Category News Views 272

Unveiling Meiyume at Cosmopack Asia 2025 Hong Kong, leading the way in beauty solutions, is set to host an influential event as Meiyume showcases its innovative initiative titled SEEDED — Rooted in Intelligence, Connected Through the Beauty Vein at Cosmopack Asia. With a strong foothold in packaging and product development, Meiyume leverages its proprietary Beauty...

Continue Reading
MAHA Action, Inc. Announces Support for Zach Lahn's Governor Bid

Updated Category News Views 215

MAHA Action, Inc. Endorses Zach Lahn for Iowa Governor MAHA™ Action, Inc., a prominent advocate for health freedom, proudly announces its endorsement of Zach Lahn as the next Governor of Iowa. Lahn has launched an Iowa First platform aimed at empowering residents and improving personal liberties. Commitment to Health Freedom Lahn has emerged as a vigorous champion of...

Continue Reading
Couchbase Reports Impressive Q1 Earnings Amid Rising Demand

Updated Category News Views 309

Financial Performance Highlights for Couchbase Couchbase, Inc. (NASDAQ: BASE), the leading developer data platform that powers critical applications in today’s AI-driven world, has unveiled its financial performance for the first quarter ended April 30, 2025. With a remarkable increase in revenue and strong annual recurring revenue (ARR), Couchbase has demonstrated the...

Continue Reading